Navigation Links
Alexza's Staccato® Nicotine Licensed to Cypress Bioscience
Date:8/26/2010

ug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. (Click here to see an animation of how the Staccato system works.)

AZ-004 (Staccato loxapine) is Alexza's lead program, which is being developed for the rapid treatment of agitation in schizophrenic or bipolar disorder patients.  Alexza has completed and announced positive results from both of its AZ-004 Phase 3 clinical trials, submitted a New Drug Application in December 2009, and has a Prescription Drug User Fee Act (PDUFA) goal date of October 11, 2010.  In February 2010, Alexza established a partnership with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 in the U.S. and Canada.  

Alexza recently announced that it plans to advance AZ-007 (Staccato zaleplon) into Phase 2 clinical development, with the first Phase 2 clinical trial projected to begin in 1H 2011.  AZ-007 is being developed for the treatment of insomnia in patients who have difficulty falling asleep, including those patients who awake in the middle of the night and have difficulty falling back asleep.

For more information about Alexza, the Staccato technology or the Company's development programs, please visit www.alexza.com.

Safe Harbor Statement

This press release includes forward-looking statements regarding the development and safety of the Company's product candidates and technologies.  Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement.  Such state
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy
2. Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product
3. Care to Care Licensed to Manage High-cost Radiology in Virginia
4. Liquid Tissue(R) Patent Licensed for Amyloidosis Proteomic Assay
5. Stem Cell Sciences Announces the Creation of the Worlds First Authentic Rat Embryonic Stem Cells from its Exclusively Licensed Technology
6. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
8. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Management of Fibromyalgia
9. SELECT TRIAL Used Selenomethionine Instead of High-Selenium Yeast, SelenoExcell(R) - Previous Research has Shown SelenoExcell(R) Supplementation to Reduce Lung, Colon and Prostate Cancers by as Much as 63%, Says Cypress Systems, Inc.
10. InQ Biosciences Appoints John Ryder as Senior Vice President, Sales & Marketing
11. Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)...  Breg, Inc., a premier provider of sports ... knee brace with new innovations to help people, ... to active lifestyles.  FreeRunner,s patent-pending design acts on ... when patients need it most, and the ability ... Patellofemoral issues are the most common cause of ...
(Date:7/10/2014)... 2014  RESMED INC. (NYSE: RMD ) today ... year ended June 30, 2014 results on Thursday, July 31, ... press release with ResMed,s results will be issued after 1:00 ... webcast to discuss operating results and future outlook. ... US Pacific Time and the live webcast of the call ...
(Date:7/10/2014)... July 10, 2014  BC Technical, the largest nationwide, ... America , Inc., a leading provider of Siemens Nuclear ... long-term agreement naming BC Technical as the authorized provider ... MiE and BC Technical announced today that the ... BC Technical as the service and systems provider for ...
Breaking Medicine Technology:Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2
... 2011 Symmetry Medical Inc. (NYSE: ... medical device solutions, including orthopedic implants, surgical instruments, ... it has signed a definitive agreement to acquire ... design, development and manufacturing of electrosurgical instruments and ...
... Aug. 3, 2011 Thoratec Corporation (NASDAQ: ... support therapies to save, support and restore failing hearts, ... were $111.2 million, a 17 percent increase over revenues ... Results for all periods of fiscal 2010 ...
Cached Medicine Technology:Symmetry Medical to Acquire Olsen Medical 2Symmetry Medical to Acquire Olsen Medical 3Thoratec Reports Second Quarter Revenue Increase of 17 Percent 2Thoratec Reports Second Quarter Revenue Increase of 17 Percent 3Thoratec Reports Second Quarter Revenue Increase of 17 Percent 4Thoratec Reports Second Quarter Revenue Increase of 17 Percent 5Thoratec Reports Second Quarter Revenue Increase of 17 Percent 6Thoratec Reports Second Quarter Revenue Increase of 17 Percent 7Thoratec Reports Second Quarter Revenue Increase of 17 Percent 8Thoratec Reports Second Quarter Revenue Increase of 17 Percent 9Thoratec Reports Second Quarter Revenue Increase of 17 Percent 10Thoratec Reports Second Quarter Revenue Increase of 17 Percent 11Thoratec Reports Second Quarter Revenue Increase of 17 Percent 12Thoratec Reports Second Quarter Revenue Increase of 17 Percent 13Thoratec Reports Second Quarter Revenue Increase of 17 Percent 14Thoratec Reports Second Quarter Revenue Increase of 17 Percent 15Thoratec Reports Second Quarter Revenue Increase of 17 Percent 16Thoratec Reports Second Quarter Revenue Increase of 17 Percent 17Thoratec Reports Second Quarter Revenue Increase of 17 Percent 18Thoratec Reports Second Quarter Revenue Increase of 17 Percent 19
(Date:7/13/2014)... Serena Gordon HealthDay Reporter ... A new type of sensor for people with diabetes is ... saliva instead of blood, researchers report. Scientists at Brown ... it using artificial saliva. It uses light, metal and a ... "Everybody knows that diabetics have to prick their fingers ...
(Date:7/13/2014)... 13, 2014 Athletes with a certain ... from concussions, according to research presented today at the ... Annual Meeting. The research marks the first of its ... the known physical events that occur after a head ... long allele in the (GT)n genotype were four times ...
(Date:7/13/2014)... Recently, 2014QuinceaneraDresses.com, the distinguished special occasion dress manufacturer ... gorgeous Quinceanera dresses . , In ... outfits is huge. Therefore, 2014QuinceaneraDresses.com is striving to ... released dresses are made according to the latest ... , It is worthy of mention that ...
(Date:7/13/2014)... Recently, MyDressCity.com, one of the most popular suppliers ... released its new range of elegant Quinceanera dresses ... at discounted prices. Worldwide clients can enjoy this special ... company’s online shop, there are plenty of beautiful dresses ... great materials. MyDressCity.com’s hot items are prom gowns, bridesmaid ...
(Date:7/13/2014)... Epidemiologists forecast an increase in the diagnosed ... diagnosed incident cases in 2013 to 11,568 diagnosed incident ... of 4.35%, during the forecast period. In 2023, the ... cases of aGVHD in the 6MM, with 4,989 diagnosed ... of diagnosed incident cases of aGVHD, with 704 diagnosed ...
Breaking Medicine News(10 mins):Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 2Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 3Health News:Genetic Factors May Be Responsible for Slowing Concussion Recovery in Athletes 2Health News:2014QuinceaneraDresses.com Releases Its New Quinceanera Dresses 2Health News:Cheap Elegant Quinceanera Dresses Unveiled by MyDressCity.com 2Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 2Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 3Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 4
... Calif, Nov. 3 BioMarin Pharmaceutical,Inc. (Nasdaq: ... Morquio Clinical,Assessment Program (MorCAP) for patients with the ... Morquio A Syndrome. MorCAP is,designed to augment available ... function and other parameters in affected patients.,BioMarin expects ...
... Services Cited as Pivotal to ... Efficiency Statewide, NASHVILLE, Tenn., Nov. 3 Emdeon, ... for the healthcare industry,has been named the electronic data ... Association (MHA). Emdeon was selected,through a competitive bidding process ...
... Va., Nov. 3 "When my father was formally,diagnosed ... book,pamphlet, and newspaper article I could get my hands ... Conversation About Alzheimer,s" (published by,AuthorHouse -- http://www.authorhouse.com ). ... I told myself that once I knew the facts, ...
... its inaugural list of the top 100, ... a leading,provider of kidney care services for those ... named in the top 100 of Modern Healthcare,s,Best ... on the list, is,the only nationwide healthcare services ...
... Nov. 3 Sabin Robbins, a,75-year old prostate ... Florida to benefit from treatment with new RapidArc(TM),radiotherapy ... Cancer Center of Boynton Beach, Florida. RapidArc, which ... ), unleashes the precision of,intensity-modulated radiation therapy (IMRT) ...
... MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: MBRK ), ... novel anti-infective products, today,announced that it has ... VCG,& Associates will serve as MiddleBrook,s strategic ... pricing and reimbursement, contract,administration, national account management ...
Cached Medicine News:Health News:BioMarin Announces Initiation of Clinical Assessment Program for Morquio A Syndrome 2Health News:BioMarin Announces Initiation of Clinical Assessment Program for Morquio A Syndrome 3Health News:BioMarin Announces Initiation of Clinical Assessment Program for Morquio A Syndrome 4Health News:Emdeon Selected by the Maryland Hospital Association to Power the Maryland Transaction Data Interchange 2Health News:'A Conversation About Alzheimer's': Woman Shares Story of Love, Hope, Loss and Survival in New Book About Alzheimer's Disease 2Health News:Modern Healthcare Names DaVita One of the Best Places to Work 2Health News:Cancer Patients in Southeastern Florida Now Benefiting From RapidArc(TM) Radiotherapy Treatments 2Health News:Cancer Patients in Southeastern Florida Now Benefiting From RapidArc(TM) Radiotherapy Treatments 3Health News:MiddleBrook Pharmaceuticals Retains National Account Firm VCG & Associates 2Health News:MiddleBrook Pharmaceuticals Retains National Account Firm VCG & Associates 3
... Neuroprene™ soft supports are a ... to proprioceptive taping for common orthopedic ... help provide specific compression and lateral ... receptors (proprioceptors) in the skin and ...
... low-profile, wraparound, hinged knee product with an ... who have difficulty applying a sleeve, the ... ease of application. These pull points ... secure the anterior closure of the garment. ...
... innovative, new padding system from Innovation Sports. ... and contours to the unique anatomy of ... Plus, Gel Fit's proprietary Octogrip™ Anti-Slip System ... seal when the brace is strapped on. ...
... the world's most versatile functional knee brace. ... or both, Flex is equipped for the ... control flexion and extension and its carbon ... heat-moldable to accommodate changes in leg shape ...
Medicine Products: